Dream Pharma announces exclusive distribution agreement with Nihon Nohyaku for luliconazole

Published: 2007-10-01 06:56:00

Updated: 2007-10-01 06:56:00

Dream Pharma Corporation announced on September 27 the execution of license agreement with Nihon Nohyaku Co. (Tokyo, Japan), an agrochemical and pharmaceutical manufacturer, granting Janus for an exclusive development and sales of a novel antifungal drug "luliconazole" in Korea.

Luliconazole was co-developed by NNC and POLA PHARMA INC. (Tokyo, Japan) and obtained approval in April 2005 in Ja...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.